Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer

SIMPLE SUMMARY: Immunotherapy is approved in selected cases of gastric cancer, and durable responses have been observed in exceptional responders. Several potential predictive biomarkers have been identified in gastric cancer, such as microsatellite instability-high (MSI-H), Epstein–Barr virus (EBV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hung-Yuan, Li, Chung-Pin, Huang, Yi-Hsiang, Hsu, Shao-Jung, Wang, Yen-Po, Hsieh, Yun-Cheng, Fang, Wen-Liang, Huang, Kuo-Hung, Li, Anna Fen-Yau, Lee, Rheun-Chuan, Lee, Kang-Lung, Wu, Yuan-Hung, Lai, I-Chun, Yang, Wan-Chin, Hung, Yi-Ping, Wang, Yu-Chao, Chen, Shu-Hui, Chen, Ming-Huang, Chao, Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750088/
https://www.ncbi.nlm.nih.gov/pubmed/35008382
http://dx.doi.org/10.3390/cancers14010218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750088/
https://www.ncbi.nlm.nih.gov/pubmed/35008382
http://dx.doi.org/10.3390/cancers14010218

Ejemplares similares